Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates.

MLA

Barbara, Ruozi, et al. “Novel Curcumin Loaded Nanoparticles Engineered for Blood-Brain Barrier Crossing and Able to Disrupt Abeta Aggregates.” International Journal of Pharmaceutics, vol. 526, no. 1–2, June 2017, pp. 413–24. EBSCOhost, https://doi.org/10.1016/j.ijpharm.2017.05.015.

APA

Barbara, R., Belletti, D., Pederzoli, F., Masoni, M., Keller, J., Ballestrazzi, A., Vandelli, M. A., Tosi, G., & Grabrucker, A. M. (2017). Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates. International Journal of Pharmaceutics, 526(1–2), 413–424. https://doi.org/10.1016/j.ijpharm.2017.05.015

Chicago

Barbara, Ruozi, Daniela Belletti, Francesca Pederzoli, Martina Masoni, Johannes Keller, Antonio Ballestrazzi, Maria Angela Vandelli, Giovanni Tosi, and Andreas M Grabrucker. 2017. “Novel Curcumin Loaded Nanoparticles Engineered for Blood-Brain Barrier Crossing and Able to Disrupt Abeta Aggregates.” International Journal of Pharmaceutics 526 (1–2): 413–24. doi:10.1016/j.ijpharm.2017.05.015.